Patrick V. Roth

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 229 publications

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Serum Glial Fibrillary Acidic Protein Dynamics, Disease Progression, and Therapy Response in Multiple Sclerosis.

Journal: JAMA neurology

Published: August 03, 2026

Intratumoral hemorrhage in patients with brain metastasis from systemic tumors: risk factors and prognostic assessment.

Intratumoral hemorrhage in patients with brain metastasis from systemic tumors: risk factors and prognostic assessment.

Journal: Journal of neuro-oncology

Published: May 25, 2026

Disease Course After Anti-CD20 Discontinuation in Secondary Progressive Multiple Sclerosis-A Multicenter Long-Term Longitudinal Study.

Disease Course After Anti-CD20 Discontinuation in Secondary Progressive Multiple Sclerosis-A Multicenter Long-Term Longitudinal Study.

Journal: Annals of clinical and translational neurology

Published: May 07, 2026

Two cases of probable Neuro-Behçet syndrome treated with autologous HSCT.

Two cases of probable Neuro-Behçet syndrome treated with autologous HSCT.

Journal: Frontiers in immunology

Published: April 24, 2026

Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 23, 2026

Keeping cool - how persons with MS manage heat sensitivity: Insights from the Swiss multiple sclerosis registry.

Keeping cool - how persons with MS manage heat sensitivity: Insights from the Swiss multiple sclerosis registry.

Journal: Multiple sclerosis and related disorders

Published: April 08, 2026

A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningioma.

A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningioma.

Journal: Neuro-oncology advances

Published: March 17, 2026

Prognostic Role of Ventricular Size and Its Dynamics in Patients With Leptomeningeal Metastasis From Solid Tumors.

Prognostic Role of Ventricular Size and Its Dynamics in Patients With Leptomeningeal Metastasis From Solid Tumors.

Journal: Neurology

Published: January 15, 2026

Potent antitumor activity through dual targeting of PD-L1 and TGF-β pathways in the glioma tumor microenvironment.

Potent antitumor activity through dual targeting of PD-L1 and TGF-β pathways in the glioma tumor microenvironment.

Journal: Journal for immunotherapy of cancer

Published: January 13, 2026

Multifunctional Nanodiamond Conjugate With a Tumor-Specific EGFR-Targeting Peptide and Photoactivated CO Release for Improved Therapeutic Efficacy in Head and Neck Cancers.

Multifunctional Nanodiamond Conjugate With a Tumor-Specific EGFR-Targeting Peptide and Photoactivated CO Release for Improved Therapeutic Efficacy in Head and Neck Cancers.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: January 13, 2026

Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosis.

Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosis.

Journal: BMJ neurology open

Published: December 04, 2025

Structural basis of Mlc-mediated transcriptional regulation of carbohydrate metabolism.

Structural basis of Mlc-mediated transcriptional regulation of carbohydrate metabolism.

Journal: Nature communications

Published: November 28, 2025

Showing 1-12 of 229

Last Updated: 09/26/2026